首页> 外文期刊>Cellular immunology >Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.
【24h】

Paclitaxel enhances early dendritic cell maturation and function through TLR4 signaling in mice.

机译:紫杉醇通过TLR4信号转导小鼠增强树突状细胞的早期成熟和功能。

获取原文
获取原文并翻译 | 示例
       

摘要

Subclinical doses of Paclitaxel (PTX) given 1day prior to a HER-2eu (neu)-targeted, granulocyte-macrophage colony stimulating factor (GM-CSF)-secreting whole-cell vaccine enhances neu-specific T cell responses and slows neu(+) tumor growth in tolerized HER-2eu (neu-N) mice. We demonstrate that co-administration of PTX and Cyclophosphamide (CY) synergizes to slow tumor growth, and that in vitro, DC precursors exposed to PTX before LPS maturation results in greater co-stimulatory molecule expression, IL-12 production, and the ability to induce CD8(+) T cells with enhanced lytic activity against neu(+) tumors. PTX treatment also enhances maturation marker expression on CD11c(+) DCs isolated from vaccine-draining lymph nodes. Ex vivo, these DCs activate CD8(+) T cells with greater lytic capability than DC's from vaccine alone-treated neu-N mice. Finally, PTX treatment results in enhanced antigen-specific, IFN-gamma-secreting CD8(+) T cells in vivo. Thus, administration of PTX with a tumor vaccine improves T cell priming through enhanced maturation of DC.
机译:在靶向HER-2 / neu(neu)的粒细胞巨噬细胞集落刺激因子(GM-CSF)分泌全细胞疫苗之前1天给予亚临床剂量的紫杉醇(PTX),可增强neu特异性T细胞反应并减缓neu (+)耐受的HER-2 / neu(neu-N)小鼠的肿瘤生长。我们证明PTX和环磷酰胺(CY)的共同给药可协同减慢肿瘤的生长,并且在LPS成熟之前体外暴露于PTX的DC前体会导致更大的共刺激分子表达,IL-12产生以及诱导具有增强的针对neu(+)肿瘤的裂解活性的CD8(+)T细胞。 PTX处理还增强了从疫苗引流淋巴结分离的CD11c(+)DC上的成熟标记表达。在体外,这些DC激活CD8(+)T细胞的裂解能力比单独疫苗治疗的neu-N小鼠的DC更高。最后,PTX治疗可增强体内抗原特异性,分泌IFN-γ的CD8(+)T细胞的功能。因此,将PTX与肿瘤疫苗一起施用可通过增强DC的成熟来改善T细胞的启动。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号